Provided by Tiger Trade Technology Pte. Ltd.

DexCom

68.10
-2.5900-3.66%
Post-market: 67.91-0.1900-0.28%17:39 EST
Volume:3.93M
Turnover:268.51M
Market Cap:26.21B
PE:32.59
High:69.86
Open:69.72
Low:67.64
Close:70.69
52wk High:89.98
52wk Low:54.11
Shares:384.86M
Float Shares:382.00M
Volume Ratio:0.94
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.09
EPS(LYR):2.09
ROE:34.50%
ROA:8.89%
PB:9.54
PE(LYR):32.59

Loading ...

Interim CEO of DexCom Jacob Leach Buys 6.6% More Shares

Simply Wall St.
·
Nov 14, 2025

Rothschild & Co Redburn Adjusts DexCom Price Target to $90 From $115, Maintains Buy Rating

MT Newswires Live
·
Nov 13, 2025

DexCom Director Bridgette P. Heller Reports Sale of Common Shares

Reuters
·
Nov 13, 2025

DexCom Inc. Stock Climbs 6.0%, Outperforms Peers

Dow Jones
·
Nov 12, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2025-11-11

Reuters
·
Nov 12, 2025

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

Reuters
·
Nov 12, 2025

DexCom Director Richard Alexander Collins Reports Sale of Common Shares

Reuters
·
Nov 11, 2025

DexCom price target lowered to $63 from $89 at Morgan Stanley

TIPRANKS
·
Nov 11, 2025

Celldex Therapeutics Appoints Teri Lawver as Chief Commercial Officer

Reuters
·
Nov 10, 2025

Why TAL Education, Shake Shack And DexCom Just Appeared On Value Investors' Radars

Benzinga
·
Nov 08, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2025-11-07

Reuters
·
Nov 08, 2025

Dexcom: A Compelling Buy Amid Operational Improvements and Market Opportunities

TIPRANKS
·
Nov 08, 2025

Argus Research Adjusts DexCom Price Target to $90 From $100

MT Newswires Live
·
Nov 08, 2025

DexCom Is Maintained at Buy by Argus Research

Dow Jones
·
Nov 08, 2025

QuÉBec Expands Access to Dexcom Cgm Under the RÉGie De L'assurance Maladie Du QuÉBec (Ramq)

THOMSON REUTERS
·
Nov 07, 2025

DexCom Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Nov 07, 2025

DexCom Faces Investor Class Action Over Alleged Securities Fraud

Reuters
·
Nov 07, 2025

Insulet tops quarterly estimates on demand for wearable insulin pumps

Reuters
·
Nov 06, 2025

Insulet Q3 revenue, profit beat expectations on Omnipod demand

Reuters
·
Nov 06, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-11-05

Reuters
·
Nov 06, 2025